MN
Minerva Neurosciences Inc
🇺🇸XNAS.NERVUnited StatesHealthcare
$3.62USDdown -0.21 (-5.48%)OpenDelayed7:28 PM
Price$3.62-0.21 (-5.48%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US6033802058
- CUSIP
- 603380106
Company
- Employees
- 7
- Headquarters
- Burlington, United States
- CEO
- Dr. Remy Luthringer Ph.D.
Market
- Shares outstanding
- 47.7M
- Market cap
- $172.85M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $184.31M
- EPS LTM
- -$4.99
- P/E LTM
- -1.13
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$394.35M-3,611.7%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$18.78B-112,163.14%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.